Sephience Powder
Product Images NDC 52856-201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Sephience (NDC 52856-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ptc Therapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sephience 01)

FDA Label Image

Figure 1 (Sephience 02)

FDA Label Image

250mg Dose Packet (Sephience 03)

250mg Dose Packet (Sephience 03)
This text provides information about Sephience (sepiapterin) oral powder, with each packet containing 250 mg. The product comes in a box of 30 packets.*
FDA Label Image

1000mg Dose Packet (Sephience 04)

1000mg Dose Packet (Sephience 04)
This is information about SEPHIENCE (sepiapterin) Oral Powder. Each packet contains 1,000 mg of sepiapterin and there are 30 packets in a box.*
FDA Label Image

Figure A (Sephience 05)

Figure A (Sephience 05)
This is a description of items included and not included in a package. It includes SEPHIENCE oral powder packets but does not include an oral dosing syringe, scissors, container water, or an apple juice cup for mixing.*
FDA Label Image

Figure B (Sephience 06)

Figure B (Sephience 06)
This text provides information about a figure labeled as "Figure B" which appears to be a container used for mixing substances or ingredients.*
FDA Label Image

Figure C (Sephience 07)

Figure C (Sephience 07)
This description appears to be a list of items found in Figure C, including a barrel, plunger, oral dosing syringe, container, water or apple, for mixing juice cup. These items likely relate to a demonstration or step-by-step guide on how to use them together.*
FDA Label Image

Figure D (Sephience 08)

Figure D (Sephience 08)
A useful description based on the provided text is: "Figure D shows a container designed for mixing various substances or ingredients."*
FDA Label Image

Figure E (Sephience 09)

FDA Label Image

Figure F (Sephience 10)

FDA Label Image

Figure G (Sephience 11)

FDA Label Image

Figure A1 (Sephience 12)

Figure A1 (Sephience 12)
This description is not available.*
FDA Label Image

250mg Foil (Sephience 13)

FDA Label Image

1000mg Foil (Sephience 14)

1000mg Foil (Sephience 14)
"Sephience" is an oral powder supplement available in packets containing 250mg per serving.*
FDA Label Image

Figure B1 (Sephience 15)

Figure B1 (Sephience 15)
A description is not available.*
FDA Label Image

Figure C1 (Sephience 16)

Figure C1 (Sephience 16)
This text seems to describe a recipe or a step-by-step guide for making a dish that includes ingredients such as applesauce, strawberry jam, apple juice, and a tablespoon for mixing. It may likely involve a process of combining these ingredients in a container.*
FDA Label Image

Figure D1 (Sephience 17)

FDA Label Image

Ndc: 52856-201-03 (250mg Carton Label)

Ndc: 52856-201-03 (250mg Carton Label)
This is a description of Sephience (sepiapterin) Oral Powder, which comes in packets containing 250 mg each. It is recommended to take this powder with food and follow the enclosed instructions for administration. Each box contains 30 unit-dose packets with no preservatives. The recommended dosage can be found in the Prescribing Information. The product should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (50°F to 86°F). Manufactured by PTC Therapeutics, Inc., located in Warren, NJ, USA.*
FDA Label Image

Ndc: 52856-201-01 (250mg Sachet Label)

Ndc: 52856-201-01 (250mg Sachet Label)
This is a label for Sephience (sepiapterin) Oral Powder with a strength of 250 mg per packet. The product is manufactured for PTC Therapeutics, Inc. The directions indicate to take the powder with food and reference enclosed instructions for further guidance on administration.*
FDA Label Image

Ndc: 52856-201-01 (250mg Sachet Foil)

Ndc: 52856-201-01 (250mg Sachet Foil)
This text provides information about a medication called "Sephience" which is an oral powder containing 250 mg per packet. It includes directions to take the medication with food and refers to enclosed instructions for administration guidance. The medication is associated with the NDC number 52856-201-01 and is manufactured for PTC Therapeutics, Inc.*
FDA Label Image

Ndc: 52856-301-03 (1000mg Carton Label)

Ndc: 52856-301-03 (1000mg Carton Label)
This text appears to be a product description or label for a medical supplement called "Sephience". It includes information about the dosage (1,000 mg per packet), directions for use, storage recommendations, manufacturer details (PTC Therapeutics, Inc.), and instructions for administration. The product is in oral powder form and is packaged in 30 unit-dose packets. It is noted that the product contains no preservatives and any unused portion should be discarded. It also mentions to refer to the prescribing information for the recommended dosage. Additionally, the text suggests taking the supplement with food.*
FDA Label Image

Ndc: 52856-301-01 (1000mg Sachet Label)

Ndc: 52856-301-01 (1000mg Sachet Label)
This text provides information about a medication by PTC Therapeutics, Inc. It is in the form of oral powder with a strength of 1,000 mg per packet. The directions advise taking the medication with food and refer to enclosed instructions for administration details. The front label and back label are also mentioned, along with the NDC code and manufacturing details.*
FDA Label Image

Ndc: 52856-301-01 (1000mg Sachet Foil)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.